Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Aspira Women's Health Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 25 | 2 | −23 |
| Shares | 864.2K | 110.6K | −753.6K (−87.2%) |
| Value | $81.0K | $15.7K | −$65.3K (−80.6%) |
New holders (0)
Institutions that held Aspira Women's Health Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (23)
Institutions that held Aspira Women's Health Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| HRT Financial LP | 182,286 | $17.0K |
| Geode Capital Management, LLC | 131,968 | $12.4K |
| BlackRock, Inc. | 82,232 | $7.72K |
| Vanguard Group Inc | 79,183 | $7.44K |
| Bank of America Corp | 63,528 | $5.91K |
| Virtu Financial LLC | 52,851 | $5.00K |
| UBS Group AG | 34,196 | $3.21K |
| Pine Valley Investments Ltd Liability Co | 33,400 | $3.14K |
| Two Sigma Securities, LLC | 29,808 | $2.80K |
| The PNC Financial Services Group, Inc. | 25,000 | $2.35K |
| Northeast Financial Consultants Inc | 23,436 | $2.20K |
| State Street Corp | 19,749 | $1.85K |
| Northern Trust Corp | 16,799 | $1.58K |
| M&T Bank Corp | 14,999 | $1.41K |
| Tower Research Capital LLC (TRC) | 4,130 | $388 |
| JPMorgan Chase & Co | 2,061 | $194 |
| Morgan Stanley | 1,694 | $159 |
| Operose Advisors LLC | 1,000 | $94 |
| BNP Paribas Arbitrage, SA | 610 | $57 |
| SBI Securities Co., Ltd. | 199 | $19 |
| Group One Trading, L.P. | 119 | $11 |
| Danske Bank A/S | 1 | $0 |
| Royal Bank of Canada | 100 | $0 |